Asthma Therapeutics Market Growth Patterns And Forecast Outlook Through 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Asthma Therapeutics Market Be By 2030 Compared To Its 2026 Market Size?

The asthma therapeutics market size has experienced significant expansion in recent years. It is projected to grow from $33.11 billion in 2025 to $35.73 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.9%. This historical growth can be attributed to several factors including the limited availability of biologics, a reliance on short-acting beta agonists, the rising prevalence of asthma globally, an increase in hospital and specialty clinic visits, and the widespread adoption of oral and inhaled medications.

The asthma therapeutics market is projected to experience robust expansion over the coming years. This market is set to reach $47.87 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.6%. This anticipated growth throughout the forecast period stems from factors such as the creation of innovative biologics and combination treatments, the wider adoption of telemedicine and digital health monitoring, increasing awareness of preventive care, improved access to healthcare in developing economies, and increased investment in research and drug development. Key developments expected during this period involve the increasing embrace of personalized asthma treatments, a rise in the utilization of inhalers and biologic medications, the proliferation of homecare and remote monitoring systems, a growing preference for combination inhaler products, and an intensified focus on managing asthma in pediatric and geriatric populations.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25702&type=smp

What Significant Factors Are Influencing The Asthma Therapeutics Market Expansion?

The rising occurrence of asthma is projected to drive the expansion of the asthma therapeutics market in the future. Asthma is defined as a chronic condition characterized by inflammation and swelling of the air passages, leading to a constriction of the pathways that transport air from the nose and mouth to the lungs. This growing incidence of asthma can be attributed to a rise in pollutants, which irritate the respiratory tracts and elevate the likelihood of acquiring the condition. Asthma therapeutics assist in managing the condition by regulating inflammation in the airways, alleviating symptoms, and averting asthma attacks. For example, as reported by the UK Parliament, a UK-based government organization, in May 2025, a total of 3,886,879 individuals aged six and above were diagnosed with asthma during 2023-24, making up 6.5% of England’s population. Consequently, the growing frequency of asthma is fueling the development of the asthma therapeutics market.

Which Segment Classifications Are Used In The Asthma Therapeutics Market Segment Analysis?

The asthma therapeutics market covered in this report is segmented –

1) By Drug Class: Inhaled Corticosteroids (ICS), Long-Acting Beta Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Short-Acting Beta Agonists (SABA), Biologics, Combination Inhalers (ICS + LABA)

2) By Treatment Stage: Acute Treatment, Long-Term Control, Preventive Treatment, Maintenance Regimens, Rescue Medications

3) By Route Of administration: Oral, Inhaled, Intravenous, Subcutaneous

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End-User: Hospitals, Homecare, Specialty Clinics

Subsegments:

1) By Inhaled Corticosteroids (ICS): Fluticasone, Budesonide, Beclomethasone, Mometasone, Ciclesonide

2) By Long-Acting Beta Agonists (LABA): Salmeterol, Formoterol, Indacaterol, Olodaterol

3) By Leukotriene Receptor Antagonists (LTRA): Montelukast, Zafirlukast, Pranlukast

4) By Short-Acting Beta Agonists (SABA): Albuterol (Salbutamol), Levalbuterol, Terbutaline

5) By Biologics: Omalizumab, Mepolizumab, Benralizumab, Dupilumab, Reslizumab

6) By Combination Inhalers (ICS + LABA): Fluticasone + Salmeterol, Budesonide + Formoterol, Mometasone + Indacaterol, Beclomethasone + Formoterol

What Trends Are Affecting The Direction Of The Asthma Therapeutics Market?

Leading firms in the asthma therapeutics sector are concentrating on creating novel solutions, including anti-inflammatory rescue inhalers, to improve symptom alleviation, manage inflammation, and advance comprehensive disease management. This type of rescue inhaler represents a dual-action therapy, merging a quick-acting bronchodilator with an inhaled corticosteroid within one device, thereby allowing for swift bronchodilation, immediate inflammation decrease, and the avoidance of acute asthma episodes. An example is AstraZeneca plc, a UK-based biopharmaceutical company, which introduced AIRSUPRA in January 2024. This FDA-approved anti-inflammatory rescue inhaler is engineered to provide instant symptom alleviation coupled with rapid anti-inflammatory effects, offering as-needed dual-mechanism dosing, real-time suppression of airway inflammation, and assistance in preventing the decline of lung function linked to exacerbations. AIRSUPRA contributes to better asthma management, lowers the likelihood of severe attacks, and enhances the overall efficacy of rescue therapies.

Which Firms Are Contributing To The Asthma Therapeutics Market Ecosystem?

Major companies operating in the asthma therapeutics market are Roche Holding AG, Merck & Co Inc., Pfizer Inc., AstraZeneca plc, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited, Mylan N.V.

Get The Full Asthma Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/report/asthma-therapeutics-global-market-report

Where Is The Asthma Therapeutics Market Primarily Concentrated By Region?

North America was the largest region in the asthma therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Asthma Therapeutics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/asthma-therapeutics-global-market-report

Browse Through More Reports Similar to the Global Asthma Therapeutics Market 2026, By The Business Research Company

Asthma Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795